http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
추욱진(WJ Chu),방보영(BY Bang),권현정(HJ Kwon),최유덕(YD Choi),하승연(SY Ha),박성혜(SH Park),박흠례(HR Park) 대한산부인과학회 1997 Obstetrics & Gynecology Science Vol.40 No.5
Tuberculosis of the vulva is very rare and is of interest because it clinically may resemble carcinoma which should be ruled out in the differential diagnosis of the indurated ulcerating lesion of the vulva. We experienced a case of tuberculosis of the vulva and report with a brief review of literature.
권현정(HJ Kwon),추욱진(WJ Chu),방보영(BY Bang),최광엽(KY Choi),최유덕(YD Choi) 대한산부인과학회 1997 Obstetrics & Gynecology Science Vol.40 No.5
Fibromatous tumors of the ovary are considered to originate from specialized ovarian stromal cells and account for approximately 4% of all ovarian neoplasms. Most ovarian fibromatous tumors are benign, but infrequently there are histologically malignant appearances. Malignant fibromatous tumor can be categorized into two separate types of tumors relating to prognosis, cellular fibroma and fibrosarcoma. The cellular fibroma has one to three mitotic counts per 10 high power fields(HPF). Unless an adhesion or rupture appears on this tumor, recurrence should not happen after operation. Furthermore, where the mitotic count per 10 HPF is over four, it is classified as a very bad fibrosarcoma case in terms of prognosis. We have met a case of large ovarian fibrosarcoma with has ten mitotic counts per 10 HPF. We hereby report this case with the brief review of literatures.
난소 상피성종양에서 원발성과 전이성을 감별 진단하기 위한 면역조직화학적 연구
방보영(BY Bang),권현정(HJ Kwon),추욱진(WJ Chu),김휴(H Kim),최광엽(KY Choi),최유덕(YD Choi),이미자(MJ Lee),전호종(HJ Jeon) 대한산부인과학회 1997 Obstetrics & Gynecology Science Vol.40 No.5
To determine the distinction of primary ovarian carcinoma from metastatic ovarian carcinoma, the author studied total 40 cases of malignant tumors(13 primary ovarian carcinomas: 7 serous, 4 mucinous, and 2 endometrioid, 7 metastatic ovarian adenocarcinomas, 10 gastric adenocarcinomas and 10 colonic adenocarcinomas) using primary antibody to CEA, CK7, CK20 and CK18. The results were summerised as follows: The expression of CK7 was demonstrated in all(7) serous and 3 out of 4 mucinous adenocarcinoma, and 1 out of 10 each gastric and colonic adenocarcinoma. The CK20 positivity was seen in 4 out of 10 cases of colonic adenocarcinoma and 3 out of 7 cases of metastatic adenocarcinoma. All primary ovarian carcinoma and gastric adenocarcinoma were negative for CK20 except for focal positivity in only 1 ovarian mucinous adenocarcinoma. All types of serous and endometrioid adenocarcinoma were negative for CEA. But, the vast majority of mucinous adenocarcinoma, metastatic adenocarcinoma, gastric and colonic adenocarcinoma were positive for CEA. The CK18 may not be helpful to differentiate the primay or metastatic carcinoma because all cases examined were positive for CK18 except for 1 ovarian mucinous carcinoma. Immunostainning for CK7 may be helpful on differential diagnosis of primary and metastatic ovarian carcinoma, especially mucinous adenocarcinoma and metastatic gastric and colonic adenocarcinoma. The CK20 may be a useful marker for differential diagosis in primary and metastatic ovarian carcinomas. The CEA may be of value on differential diagnosis of mucinous and nonmucinous(serous and endomerioid) ovarian carcinomas, and metastatic colonic adenocarcinoma and endometrioid carcinoma. In conclusion, immunohistochemical study for CEA, CK7, and CK20 may be helpful in differential diagnosis between primary and metastatic ovarian carcinoma.